Elevance Health Stock-Based Compensation — Historical Data
Elevance Health (ELV) stock-based compensation was $276M in FY2025 (+45% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$276M
+45%
2024
$191M
-34%
2023
$289M
+9%
2022
$264M
+4%
2021
$255M
-13%
2019
$294M
+30%
2018
$226M
+33%
2017
$170M
+3%
2016
$165M
+11%
2015
$148M
-12%
2014
$169M
+16%
2013
$146M
-0%
2012
$146M
+9%
2011
$135M
-1%
2010
$136M
-11%
2009
$154M
-2%
2008
$156M
-12%
2007
$177M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$75M
Q1 2026
$55M
Q4 2025
$30M
Q3 2025
$84M
Q2 2025
$81M
Q1 2025
$81M
Q4 2024
-$29M
Q3 2024
$66M
Q2 2024
$92M
Q1 2024
$62M
Q4 2023
$72M
Q3 2023
$78M
Source: ELV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.